FTSE pharmaceuticals outperforming All-Share

The UK pharmaceutical sector has displayed strong growth year to date and is expected to outperform ...

The UK pharmaceutical sector has displayed strong growth year to date and is expected to outperform the FTSE All-Share over the course of the year. Over the year to 18 May, the FTSE pharmaceuticals index is up 10.72% compared to a fall of 3.89% in the FTSE All-Share. On a 12-month view, pharmaceuticals is expected to continue to show double digit outperformance relative to the All-Share, says Ross Martin, assistant UK fund manager at Aberdeen Asset Management. Martin is bullish on pharmaceuticals, which is reflected in his fund's overweight position in the sector. He maintains a neutral...